ZA991138B - Streptomyces avermitilis gene directing the ratio of B2: B1 avermectins. - Google Patents
Streptomyces avermitilis gene directing the ratio of B2: B1 avermectins.Info
- Publication number
- ZA991138B ZA991138B ZA9901138A ZA991138A ZA991138B ZA 991138 B ZA991138 B ZA 991138B ZA 9901138 A ZA9901138 A ZA 9901138A ZA 991138 A ZA991138 A ZA 991138A ZA 991138 B ZA991138 B ZA 991138B
- Authority
- ZA
- South Africa
- Prior art keywords
- avermectins
- ratio
- streptomyces avermitilis
- gene directing
- avermitilis gene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7463698P | 1998-02-13 | 1998-02-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA991138B true ZA991138B (en) | 2000-08-14 |
Family
ID=22120706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9901138A ZA991138B (en) | 1998-02-13 | 1999-02-12 | Streptomyces avermitilis gene directing the ratio of B2: B1 avermectins. |
Country Status (32)
| Country | Link |
|---|---|
| EP (1) | EP1053335A1 (en) |
| JP (2) | JP2002503473A (en) |
| KR (3) | KR20040099389A (en) |
| CN (2) | CN1297485A (en) |
| AP (1) | AP9901463A0 (en) |
| AR (1) | AR018085A1 (en) |
| AU (1) | AU752343C (en) |
| BG (1) | BG64911B1 (en) |
| BR (1) | BR9907893A (en) |
| CA (2) | CA2320031A1 (en) |
| CO (1) | CO5070698A1 (en) |
| DZ (1) | DZ2720A1 (en) |
| EA (1) | EA003905B1 (en) |
| GT (1) | GT199900014A (en) |
| HN (1) | HN1999000008A (en) |
| HR (1) | HRP20000539A2 (en) |
| HU (1) | HUP0100784A3 (en) |
| IL (2) | IL137610A0 (en) |
| IS (1) | IS5567A (en) |
| MA (1) | MA24760A1 (en) |
| NO (1) | NO20004044L (en) |
| NZ (2) | NZ518657A (en) |
| OA (1) | OA11449A (en) |
| PA (1) | PA8467601A1 (en) |
| PE (1) | PE20000352A1 (en) |
| PL (1) | PL194270B1 (en) |
| SK (1) | SK11722000A3 (en) |
| TN (1) | TNSN99017A1 (en) |
| TW (1) | TW585910B (en) |
| WO (1) | WO1999041389A1 (en) |
| YU (1) | YU50900A (en) |
| ZA (1) | ZA991138B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ518657A (en) * | 1998-02-13 | 2003-10-31 | Pfizer Prod Inc | Streptomyces hygroscopicus directing the ratio of B2:B1 avermectins |
| US6248579B1 (en) * | 1998-02-13 | 2001-06-19 | Pfizer Inc | Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| KR100489856B1 (en) * | 1999-08-12 | 2005-05-17 | 화이자 프로덕츠 인코포레이티드 | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| US7630836B2 (en) | 2001-05-30 | 2009-12-08 | The Kitasato Institute | Polynucleotides |
| MXPA04007777A (en) * | 2002-02-12 | 2004-10-15 | Pfizer Prod Inc | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins. |
| CN107338210B (en) * | 2017-09-05 | 2021-08-17 | 天津科技大学 | Abamectin streptomycete synthetic medium and preparation method of fermentation liquor thereof |
| CN111269296B (en) * | 2020-03-06 | 2021-11-05 | 山东大学 | nLsA protein, structural gene thereof and application thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE434277B (en) * | 1976-04-19 | 1984-07-16 | Merck & Co Inc | SET TO MAKE NEW ANTIHELMINTICALLY EFFECTIVE ASSOCIATIONS BY CULTIVATING STREPTOMYCS AVERMITILIS |
| US4429042A (en) * | 1978-09-08 | 1984-01-31 | Merck & Co., Inc. | Strain of Streptomyces for producing antiparasitic compounds |
| IN167980B (en) * | 1987-01-23 | 1991-01-19 | Pfizer | |
| ATE89604T1 (en) * | 1987-10-23 | 1993-06-15 | Pfizer | PROCESS FOR THE PREPARATION OF AGLYCONES OF AVERMECTIN AND CULTURES CONTAINING THEM. |
| JPH0747171B2 (en) * | 1988-09-20 | 1995-05-24 | 株式会社東芝 | Rolling mill setting method and device |
| US5252474A (en) * | 1989-03-31 | 1993-10-12 | Merck & Co., Inc. | Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use |
| DE69023036T2 (en) * | 1989-03-31 | 1996-06-13 | Merck & Co Inc | Cloning of Streptomyces avermitilis genes for the biosynthesis of avermectin and method of using them. |
| JP2888586B2 (en) * | 1990-03-05 | 1999-05-10 | 社団法人北里研究所 | Microorganism for selective production of specific components of avermectin and its selective production method |
| FI942725A (en) * | 1993-12-16 | 1995-06-17 | Pfizer | Genes encoding branched chain alpha-keto acid dehydrogenase complex from Streptomyces avermitilis |
| NZ518657A (en) * | 1998-02-13 | 2003-10-31 | Pfizer Prod Inc | Streptomyces hygroscopicus directing the ratio of B2:B1 avermectins |
-
1999
- 1999-01-25 NZ NZ518657A patent/NZ518657A/en unknown
- 1999-01-25 CA CA002320031A patent/CA2320031A1/en not_active Abandoned
- 1999-01-25 SK SK1172-2000A patent/SK11722000A3/en unknown
- 1999-01-25 BR BR9907893-7A patent/BR9907893A/en not_active Application Discontinuation
- 1999-01-25 EP EP99900270A patent/EP1053335A1/en not_active Withdrawn
- 1999-01-25 NZ NZ505676A patent/NZ505676A/en unknown
- 1999-01-25 HU HU0100784A patent/HUP0100784A3/en not_active Application Discontinuation
- 1999-01-25 WO PCT/IB1999/000130 patent/WO1999041389A1/en not_active Application Discontinuation
- 1999-01-25 CN CN99805027A patent/CN1297485A/en active Pending
- 1999-01-25 KR KR10-2004-7015691A patent/KR20040099389A/en active Search and Examination
- 1999-01-25 KR KR10-2004-7008310A patent/KR20040053390A/en active Search and Examination
- 1999-01-25 EA EA200000758A patent/EA003905B1/en not_active IP Right Cessation
- 1999-01-25 IL IL13761099A patent/IL137610A0/en unknown
- 1999-01-25 KR KR10-2000-7008870A patent/KR100499214B1/en not_active IP Right Cessation
- 1999-01-25 CN CNA2004100054154A patent/CN1521180A/en active Pending
- 1999-01-25 AU AU18878/99A patent/AU752343C/en not_active Ceased
- 1999-01-25 YU YU50900A patent/YU50900A/en unknown
- 1999-01-25 JP JP2000531570A patent/JP2002503473A/en active Pending
- 1999-01-25 CA CA002521289A patent/CA2521289A1/en not_active Abandoned
- 1999-01-25 PL PL99342468A patent/PL194270B1/en not_active IP Right Cessation
- 1999-01-26 PA PA19998467601A patent/PA8467601A1/en unknown
- 1999-02-01 GT GT199900014A patent/GT199900014A/en unknown
- 1999-02-05 HN HN1991000008A patent/HN1999000008A/en unknown
- 1999-02-08 PE PE1999000099A patent/PE20000352A1/en not_active Application Discontinuation
- 1999-02-09 TW TW088102005A patent/TW585910B/en active
- 1999-02-10 DZ DZ990021A patent/DZ2720A1/en active
- 1999-02-10 TN TNTNSN99017A patent/TNSN99017A1/en unknown
- 1999-02-10 MA MA25460A patent/MA24760A1/en unknown
- 1999-02-11 AP APAP/P/1999/001463A patent/AP9901463A0/en unknown
- 1999-02-11 AR ARP990100571A patent/AR018085A1/en unknown
- 1999-02-12 CO CO99008652A patent/CO5070698A1/en unknown
- 1999-02-12 ZA ZA9901138A patent/ZA991138B/en unknown
-
2000
- 2000-07-20 IS IS5567A patent/IS5567A/en unknown
- 2000-08-04 OA OA1200000217A patent/OA11449A/en unknown
- 2000-08-11 HR HR20000539A patent/HRP20000539A2/en not_active Application Discontinuation
- 2000-08-11 NO NO20004044A patent/NO20004044L/en not_active Application Discontinuation
- 2000-09-12 BG BG104759A patent/BG64911B1/en unknown
-
2004
- 2004-04-27 JP JP2004130624A patent/JP4011036B2/en not_active Expired - Fee Related
-
2007
- 2007-05-31 IL IL183596A patent/IL183596A0/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1034978A1 (en) | Adenosine derivatives. | |
| ZA985018B (en) | 9-oxime erythromycin derivatives. | |
| ZA991664B (en) | 3,6-ketal and enol ether macrolide antibiotics. | |
| ZA200103289B (en) | Novel macrolide antibiotics. | |
| ZA995872B (en) | Streptomyces avermitilis regulatory genes for increased avermectin production. | |
| ZA991138B (en) | Streptomyces avermitilis gene directing the ratio of B2: B1 avermectins. | |
| HK1168383A1 (en) | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins | |
| HK1046536A1 (en) | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins. | |
| HUP0202487A3 (en) | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins | |
| AU1161500A (en) | Macrolide intermediates | |
| AU1974900A (en) | Macrolide intermediates in the preparation of clarithromycin | |
| EP1206477A4 (en) | Cloning of the streptomyces avermitilis genes for glycosylation of avermectin aglycones | |
| AU5462899A (en) | Game with action-discharge | |
| DK1200605T3 (en) | Streptomyces avermitilis gene that directs the ratio of B2: B1 avermectins | |
| AU2002323990A1 (en) | Adenosine derivatives | |
| AU2003204618A1 (en) | Novel Erythromycin Derivatives | |
| AU2003204619A1 (en) | Novel Erythromycin Derivatives | |
| AU2003204615A1 (en) | Novel Erythromycin Derivatives | |
| AU4831199A (en) | Erythromycin compositions |